Hatch BioFund
Funding rounds backed by Hatch BioFund.
- Funding disclosed in full
- $97M
- Median round
- $97M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Latus Bio, Inc. Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2 | $97MSeries A | BiotechUnited States |